|
CCT5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.78579994814766E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.01329999952138E-07 |
| Normal-vs-Stage2 |
3.52390000002423E-06 |
| Normal-vs-Stage3 |
6.76580014236094E-10 |
| Normal-vs-Stage4 |
2.87040002877603E-09 |
| Stage1-vs-Stage2 |
4.904400E-01 |
| Stage1-vs-Stage3 |
9.863400E-03 |
| Stage1-vs-Stage4 |
2.520500E-02 |
| Stage2-vs-Stage3 |
1.782220E-01 |
| Stage2-vs-Stage4 |
1.300390E-01 |
| Stage3-vs-Stage4 |
7.734400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95200000607798E-09 |
| Normal-vs-AfricanAmerican |
1.29800000003844E-06 |
| Normal-vs-Asian |
4.00700000002807E-06 |
| Caucasian-vs-AfricanAmerican |
3.427400E-01 |
| Caucasian-vs-Asian |
8.039200E-01 |
| AfricanAmerican-vs-Asian |
2.541200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.09660000471956E-08 |
| Normal-vs-Female |
3.49179996028681E-09 |
| Male-vs-Female |
5.376000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.29120000003091E-06 |
| Normal-vs-Age(41-60Yrs) |
1.36630040614705E-10 |
| Normal-vs-Age(61-80Yrs) |
3.30410000470849E-08 |
| Normal-vs-Age(81-100Yrs) |
4.396400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.585510E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.378100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.958600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.079400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.413400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.572800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.425760E-02 |
| Classical-VS-Follicular |
2.190800E-01 |
| Classical-VS-Other |
4.752200E-01 |
| Classical-VS-Normal |
2.00270000028091E-07 |
| Tall-VS-Follicular |
1.273800E-01 |
| Tall-VS-Other |
5.925600E-01 |
| Tall-VS-Normal |
1.57470000372584E-08 |
| Follicular-VS-Other |
7.666600E-01 |
| Follicular-VS-Normal |
5.05329999955784E-07 |
| Other-VS-Normal |
4.341000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.8152996013946E-10 |
| Normal-vs-N1 |
9.32840000023027E-07 |
| N0-vs-N1 |
4.922200E-01 |
|
|
